Progresses and challenges in Strongyloides spp. proteomics.
Natalia TibertiMarcello ManfrediChiara PiubelliDora BuonfratePublished in: Philosophical transactions of the Royal Society of London. Series B, Biological sciences (2023)
The availability of high-quality data of helminth genomes provided over the past two decades has supported and accelerated large-scale 'omics studies and, consequently, the achievement of a more in-depth molecular characterization of a number of pathogens. This has also involved Strongyloides spp. and since their genome was made available transcriptomics has been rather frequently applied to investigate gene expression regulation across their life cycle. Strongyloides proteomics characterization has instead been somehow neglected, with only a few reports performing high-throughput or targeted analyses associated with protein identification by tandem mass spectrometry. Such investigations are however necessary in order to discern important aspects associated with human strongyloidiasis, including understanding parasite biology and the mechanisms of host-parasite interaction, but also to identify novel diagnostic and therapeutic targets. In this review article, we will give an overview of the published proteomics studies investigating strongyloidiasis at different levels, spanning from the characterization of the somatic proteome and excretory/secretory products of different parasite stages to the investigation of potentially immunogenic proteins. Moreover, in the effort to try to start filling the current gap in host-proteomics, we will also present the first serum proteomics analysis in patients suffering from human strongyloidiasis. This article is part of the Theo Murphy meeting issue ' Strongyloides : omics to worm-free populations'.
Keyphrases
- mass spectrometry
- life cycle
- gene expression
- tandem mass spectrometry
- liquid chromatography
- single cell
- label free
- endothelial cells
- high throughput
- high performance liquid chromatography
- gas chromatography
- toxoplasma gondii
- plasmodium falciparum
- end stage renal disease
- newly diagnosed
- ultra high performance liquid chromatography
- ejection fraction
- simultaneous determination
- trypanosoma cruzi
- randomized controlled trial
- systematic review
- high resolution
- cancer therapy
- pluripotent stem cells
- dna methylation
- solid phase extraction
- prognostic factors
- peritoneal dialysis
- small molecule
- electronic health record
- machine learning
- high resolution mass spectrometry
- adverse drug
- patient reported outcomes
- ms ms
- deep learning